BCMA / NF-κB – Reporter HEK293 Recombinant Cell Line

Catalog #
79755
$11,375 *
Size: 2 vials
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

The BCMA / NF-κB - HEK293 recombinant cell line has been transfected with full-length human BCMA cDNA (Genbank #NM_001192) under control of a CMV promoter for high constitutive expression. The NF-κB–luciferase reporter is also stably integrated into the genome. The firefly luciferase gene is controlled by four copies of the NF-κB Response Element upstream of a minimal promoter. Upon ligand binding, active BCMA will initiate the NF-κB signaling pathway, leading to expression of the NF-κB-controlled luciferase reporter.

Interested in screening and profiling inhibitors, blocking antibodies, or activators of BCMA signaling without the need to purchase and license the cell line? Check out our Cell Signaling Pathway Screening.

Purchase of this cell line is for research purposes only; commercial use requires a separate license. View the full terms and conditions.

Synonyms
tumor necrosis factor receptor superfamily member 17, B-Cell Maturation Antigen, TNFRSF17, CD269, nfkb, nf-kb
Product Info
Storage and Usage
Citations
Supplied As
Two vials containing ~ 2 x 106 cells in 1 ml of 10% DMSO in FBS
Materials Required But Not Supplied

Thaw Medium 1 (BPS Bioscience, #60187)
Growth Medium 1A (BPS Bioscience #79528)
Assay Medium 7B (BPS Bioscience, #79718):
o Opti-MEM I (Life Technologies #31985-062) supplemented with 0.5% FBS
(Thermo Fisher, #26140079), 1% non-essential amino acids (Hyclone,
#SH30238.01), 1 mM Na pyruvate (Hyclone, #SH30239.01), 1%
Penicillin/Streptomycin (Hyclone, #SV30010.01).
Recombinant human BAFF (BPS Bioscience, #100194)
Recombinant human APRIL (BPS Bioscience, #100254)
• 96-well tissue culture plate or 96-well tissue culture-treated white clear-bottom assay
plate
ONE-Step™ Luciferase Assay System (BPS Bioscience, #60690)
• Luminometer

UniProt #
Q02223
Mycoplasma Testing
This cell line has been screened using the Venor™ GeM Mycoplasma Detection Kit, PCR Based (Sigma, #MP0025) to confirm the absence of Mycoplasma contamination.
Background
B-Cell Maturation Antigen (BCMA), also known as tumor necrosis factor receptor superfamily member 17 (TNFRSF17) or CD269, is a type I membrane protein encoded by the TNFRSF17 gene. TNFRSF17 is a cell surface receptor of the TNF receptor superfamily, that recognizes its ligands including BAFF (B-cell activating factor) and APRIL (a proliferation inducing ligand). BCMA is preferentially expressed in mature B lymphocytes and also on Multiple Myeloma (MM) cells. In vitro, the activation of BCMA by its ligand promotes the differentiation and proliferation of B cells. A vast array of intracellular activity is involved in BCMA-induced signal transduction, including activation of the NF-κB signaling pathway. The bioactivity of BAFF and APRIL as soluble homotrimers distinguishes them from other TNFSF ligands such as TRAIL, FasL, and CD40L, which are only active as membrane-bound molecules.
References

Hahne, M. et al. (1998) J. Exp. Med. 188:1185.
Yu, G. et al. (2000) Nat. Immunol. 1:252.
Yan, M. et al. (2000) Nat. Immunol. 1:37.
Gravestein, L.A. and Borst, J. (1998) Sem. Immunol. 10:423.